Pharmacogenomics and Personalized Medicine

译名:药物基因组学与个性化医学

Pharmacogenomics & Personalized Medicine

SCIEJCR Q3

1-3

2026

影响因子区间

平台估算

投稿周期

82%

2025

中国作者发文占比

3300 USD

费用说明

收费

期刊简介:Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.In particular, emphasis will be given to: Genomic and proteomic profilingGenetics and drug metabolismTargeted drug identification and discoveryOptimizing drug selection & dosage based on patient's genetic profileDrug related morbidity & mortality interventionAdvanced disease screening and targeted therapeutic interventionGenetic based vaccine developmentPatient satisfaction and preferenceHealth economic evaluationsPractical and organizational issues in the development and implementation of personalized medicine programs.

【译文】《药理学基因组学与个性化医疗》是一本国际性的、同行评审的、开放获取的期刊,主要研究基因型对药理学的影响,从而推动个性化治疗计划和个体化药物选择的发展,以提高安全性、有效性和可持续性。特别强调以下内容:基因组学和蛋白质组学分析、遗传学和药物代谢、靶向药物鉴定和发现、基于患者遗传特征的药物选择和剂量优化、药物相关发病率和死亡率干预、高级疾病筛查和靶向治疗干预、基于遗传的疫苗开发、患者满意度和偏好、健康经济评估、个性化医疗项目开发和实施中的实际和组织问题。

出版社
Dove Medical Press
语言
English
学科
医学
ISSN
1178-7066
eISSN
1178-7066
出版频率
年刊
创刊年份
1981
投稿网址
https://www.dovepress.com/submit_step_1.php
最近更新
2026-04-02 18:16:40
Pharmacogenomics and Personalized Medicine

指标当前值近三年趋势
JCR分区Q3
暂无
影响因子区间1-3
暂无